Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Prostatic Neoplasms 2Phyllodes Tumor 2Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymoma 1Stomach Neoplasms 1Sarcoma 1Postoperative Complications 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Mouth Neoplasms 1Lymphatic Metastasis 1High-Risk Cancer 1Carcinoma, Lobular 1

Interventions

Radiotherapy 5Cisplatin 5pembrolizumab 4Cyclophosphamide 4Thymectomy 3Sunitinib 3130-nm albumin-bound paclitaxel 3selinexor 2Pemetrexed 2Methylprednisolone 2Etoposide 2Drug Therapy 2Doxorubicin 2Chemoradiotherapy 2Carboplatin 2zimberelimab 1vorolanib 1regorafenib 1lenvatinib 1epacadostat 1envafolimab 1bosutinib 1amrubicin 1Thoracic Surgery, Video-Assisted 1TP protocol 1Ramucirumab 1Radiotherapy, Adjuvant 1Radiosurgery 1Radiofrequency Ablation 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thymoma × Radiotherapy, Adjuvant × Clear all
NCT02633553 2026-04-24

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Fudan University

Phase NA Recruiting
238 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡